BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5035658)

  • 1. [Pecularity in the structure of aglycones of cardiac glycosides with hexa-lactone cycle].
    Shilov IuM; Kotov AV; Zaĭtseva TM
    Farmatsiia; 1972; 21(3):82-5. PubMed ID: 5035658
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structure analysis of scillicyanoside pentahydrate. 58. Cardiac glycosides].
    Jaunin A; Weber HP; von Wartburg A
    Helv Chim Acta; 1973 Jul; 56(7):2117-25. PubMed ID: 4761270
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE GLYCOSIDES OF THE SEEDS OF VALLARIS SOLANACEA (ROTH) O. K. ISOLATION. GLYCOSIDES AND AGLYCONES, 263].
    KAUFMANN H; WEHRLI W; REICHSTEIN T
    Helv Chim Acta; 1965 Jan; 48():65-82. PubMed ID: 14311763
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac glycosides and aglycones by synthesis and microbiological conversion.
    Henderson FG; Chen KK
    J Med Chem; 1965 Sep; 8(5):577-9. PubMed ID: 5867937
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromatography on lipophilic dextran gels for fractionation of low molecular weight compounds II: separation of cardiac glycosides from cardiac aglycones.
    El-Olemy MM; Stohs SJ
    J Pharm Sci; 1975 Jan; 64(1):163-4. PubMed ID: 1133694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Structure and effect of cardiac glycosides from the clinical viewpoint].
    Sundermann A; Fiehring H
    Dtsch Gesundheitsw; 1967 May; 22(20):919-23. PubMed ID: 5600800
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the cardiac glycosides from the roots of Apocynum cannabinum L. 1. Isolation and separation of glycosides].
    Gerlach H; Grundmann W; Giessner R
    Pharmazie; 1965 Jul; 20(7):450-5. PubMed ID: 5882483
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac glycosides from Yellow Oleander (Thevetia peruviana) seeds.
    Kohls S; Scholz-Böttcher BM; Teske J; Zark P; Rullkötter J
    Phytochemistry; 2012 Mar; 75():114-27. PubMed ID: 22196940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The past and present of cardiac glycosides. II. Structure, physical and chemical properties. Pharmacodynamics].
    Synek P
    Cas Lek Cesk; 1989 Jan; 128(4):121-7. PubMed ID: 2720745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Color reactions of aglycones (and their glycosides) from cardiac glycosides].
    ROSENTHALER L
    Pharmazie; 1960 Aug; 15():405-9. PubMed ID: 13743504
    [No Abstract]   [Full Text] [Related]  

  • 11. [Calotropis glycosides, probable partial structure. Glycosides and aglycones. 321].
    Brüschweiler F; Stöckel K; Reichstein T
    Helv Chim Acta; 1969; 52(8):2276-303. PubMed ID: 5361918
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardenolide analogues: 10--characterization of cardiac glycosides by chemical ionization mass spectrometry.
    Vine J; Brown L; Boutagy J; Thomas R; Nelson D
    Biomed Mass Spectrom; 1979 Oct; 6(10):415-21. PubMed ID: 526557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The important aim and route of studies on cardiac glycosides (author's transl)].
    Lu FH
    Yao Xue Xue Bao; 1979; 14(10):632-40. PubMed ID: 539432
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiotonic glycoside].
    Ishii H
    Tanpakushitsu Kakusan Koso; 1969 Aug; 14(9):829-34. PubMed ID: 5389278
    [No Abstract]   [Full Text] [Related]  

  • 15. Heart glycosides in poliovirus host cell interaction. 3. Chemical structure and activity.
    Koch A; György E
    Acta Microbiol Acad Sci Hung; 1969; 16(3):245-51. PubMed ID: 4314335
    [No Abstract]   [Full Text] [Related]  

  • 16. Current drug therapy: cardiac glycosides.
    Am J Hosp Pharm; 1978 Dec; 35(12):1495-507. PubMed ID: 362913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiac glycosides: their pharmacology and clinical pharmacology].
    Greeff K
    Med Monatsschr Pharm; 1984 Feb; 7(2):37-49. PubMed ID: 6321928
    [No Abstract]   [Full Text] [Related]  

  • 18. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
    Paula S; Tabet MR; Ball WJ
    Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CHEMICAL STRUCTURE AND CLASSIFICATION OF CARDIOTONICS].
    LAPIERE CL; DALLEMAGNE MJ
    Acta Clin Belg; 1963; 18():267-76. PubMed ID: 14104725
    [No Abstract]   [Full Text] [Related]  

  • 20. [The pharmacology of cardiac glycosides].
    Noack E
    Med Klin; 1971 Apr; 66(16):583-6. PubMed ID: 4251818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.